Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

NCT01396343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1276

Last updated 2018-10-18

No results posted yet for this study

Summary

The purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or environmental exposures or a combination of both put children and adolescents at risk for getting MS.

Conditions

  • Pediatric Multiple Sclerosis

Sponsors & Collaborators

  • New York University

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • State University of New York at Buffalo

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • Boston Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • Loma Linda University

    collaborator OTHER
  • Children's Hospital Colorado

    collaborator OTHER
  • University of Texas

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • Primary Children's Hospital

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Emmanuelle L Waubant, MD, PhD · University of California, San Francisco

Eligibility

Min Age
3 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01396343 on ClinicalTrials.gov